Juvelook G — the largest particle for deep, broad areas
Juvelook G has the largest particles in the range. What large particles do, from the specifications and the studies. No prices or photos.
The short answer
Juvelook G is a 200 mg vial (170 mg PDLLA + 30 mg HA) with a mean 65 µm particle — the largest in the range, for subcutaneous use. Each particle occupies more volume (about 122,923 µm³), so the same dose supports a broader area; the manufacturer highlights broad and deep injection, tightening and contouring. In an animal study the fat layer gained volume up to 12 weeks after G. Miso Clinic in Daegu (4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu; +82 53-428-2700) stocks Juvelook G for supporting contour across broad areas.
Specifications
| Item | Detail |
|---|---|
| Vial | 200 mg (170 mg PDLLA + 30 mg HA) |
| Mean particle | 65 µm (largest) |
| Volume per particle | about 122,923 µm³ |
| Layer / use | Subcutaneous, volume |
| Highlights | Broad and deep injection, tightening, contouring |
| Approval | Tissue-repair material, class IV device; approved for temporary improvement of facial wrinkles in adults |
What large particles give
- Broad support — each particle occupies more volume, so the same dose covers more area.
- Staying power — large particles resist clearance by macrophages and stay to drive collagen.
- Fat layer — in the brochure’s animal study the fat layer gained volume at 2, 4, 8 and 12 weeks after 16 cc of G; in aged mice PDLLA also increased subcutaneous fat thickness.
Where we use it
- Broadly hollow cheeks
- Temples
- Facial contouring
Where a deep hollow needs shape straight away, I shape it first with dissolvable hyaluronic acid filler and then build the base with Juvelook. Being large, it goes deep rather than into thin skin. I start small and decide whether to add after seeing the face again a few weeks later.
Compared with Volume
Volume and G are both 200 mg and subcutaneous with the same ratio; the difference is particle size, 40 µm vs 65 µm. I lean to G for contoured support of broad, deep areas and to Volume for evenly filling gentle hollows.
Juvelook G FAQ
G vs Volume?
Both 200 mg and subcutaneous; G has a larger mean particle (65 µm vs 40 µm).
Where is G used?
Broad, deep areas and facial contouring.
Does G increase the fat layer?
In animal studies the fat layer gained volume up to 12 weeks after G, and PDLLA increased subcutaneous fat thickness in aged mice.
Where can I get a Juvelook consultation in Daegu?
Miso Clinic is on the 4th floor of the Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, in front of Exit 1 of Kyungpook National University Hospital Station. +82 53-428-2700. Weekdays 11:00–19:00, Saturdays 10:00–16:00, closed Sundays and public holidays. The clinic stocks the full Juvelook line (i, Skin, Juvelook, Volume 100, Volume and G).
Read next
Product pages
Product page: Juvelook — PDLLA with hyaluronic acid
Who wrote this
Written and reviewed by Lee Chi-Hak, MD, director of Miso Clinic, Daegu. The treatment standards and injection design set out here are the ones we use in practice.
| Medical director | Lee Chi-Hak, MD |
|---|---|
| Address | 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea · Exit 1, Kyungpook National University Hospital Station |
| Phone | +82-53-428-2700 |
| Hours | Weekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays |
| Columns | All clinical columns |
| Reference library | All booster and device references |
References
- Manufacturer brochures — VAIM Juvelook, Juvelook i and Juvelook G brochures (obtained by Miso Clinic, October 2026). Mean particle size i 20, Juvelook 24, Volume 40, G 65 µm; layer per product (i and Juvelook dermis, Volume and G subcutaneous); store below 30 °C, do not freeze; porous mesh-structured particles.
- Manufacturer product page — juvelook.co.kr (VAIM Co., Ltd.). Juvelook I and Skin 30 mg, Juvelook 50 mg, Volume 100 100 mg, Volume and G 200 mg, all 85% PDLLA and 15% hyaluronic acid. Registered in Korea as a class IV medical device (tissue-repair material) for the temporary improvement of facial wrinkles in adults.
- Subcutaneous fat — Byun KA et al., Int J Mol Sci 2024;25(23):12739, PMID 39684448. In aged mice PDLLA raised adipogenic factors and subcutaneous fat thickness without enlarging fat cells.
- Collagen and stem-cell mechanism — Oh S et al., Antioxidants 2023;12(6):1204, PMID 37371934. M2 polarisation of senescent macrophages, adipose-derived stem cell proliferation and more type I and III collagen (cells and aged mice).
- How Miso Clinic works — full Juvelook line in stock (confirmed by the director, 14–15 October 2026); concern, then layer, then product; start small and review after a few weeks; deep hollows shaped first with dissolvable hyaluronic acid filler; sagging addressed first with lifting; other options first under the eyes. Source of every “I” or “we” sentence in this column.
- Korean medical advertising law — Medical Service Act art. 56(2) and 27(3). No testimonials, before-and-after photos or prices appear here. Results and how long they last vary from person to person.
Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.
← Clinical columns · Reference library · Miso Clinic home
한국어 · English